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Infection Fatality Ratios for COVID-19 Among
Noninstitutionalized Persons 12 and Older: Results of a
Random-Sample Prevalence Study
Background: Because many cases of coronavirus disease
2019 (COVID-19) are asymptomatic, generalizable data on
the true number of persons infected are lacking. Mortality
rates therefore are calculated from confirmed cases, which
overestimates the infection fatality ratio (IFR). To calculate a
true IFR, population prevalence data are needed from large
geographic areas where reliable death data also exist. Most
previous IFR estimates came from non-U.S. populations, in-
cluding a cruise ship, or were calculated by using simulation
techniques (1–3). Previous estimates also are not age specific,
are relatively ungeneralizable, and are unsuitable for making
clinical or policy decisions.
Objective: To estimate IFRs among noninstitutionalized
(that is, community-dwelling) populations by age, race, ethnic-
ity, and sex by using the first U.S. statewide random-sample
study of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) prevalence.
Methods and Findings: We combined prevalence esti-
mates from a statewide random sample with Indiana vital sta-
tistics data of confirmed COVID-19 deaths (4). In brief, our
stratified random sample consisted of state residents aged 12
years and older. Known decedents and incarcerated persons
were excluded. Because nursing homes were limiting resi-
dents' ability to leave and re-enter the facilities, their partici-
pation was unlikely. Participants were tested from 25 April to
29 April 2020 for active viral infection and SARS-CoV-2 anti-
bodies, which would indicate prior infection. Demographic
information was collected.
We accounted for nonresponse by weighting prevalence
estimates for age, race (dichotomized as White or non-White),
and Hispanic ethnicity to reflect state demographics. Esti-
mated prevalence included all current and past infections with
bootstrapped 95% CIs. The prevalence of each demographic
stratum was multiplied by the stratum-specific state popula-
tion estimate to determine the number of cumulative infec-
tions by group.
We calculated the IFR by age, race, sex, and ethnicity on
the basis of the cumulative number of confirmed COVID-19
deaths as of 29 April 2020, divided by the number of infec-
tions. Although nursing home residents were not tested, they
represented 54.9% of Indiana's deaths. Thus, we excluded
nursing home residents from all calculations (that is, deaths
and infections). To account for all infections, we added the
number of patients hospitalized with COVID-19 during the
testing period and noninstitutionalized COVID-19 deaths into
the denominator.
As of 29 April 2020, Indiana had recorded 1099 COVID-19
deaths, 495 of which occurred in noninstitutionalized persons.
Our random-sample study estimated 187 802 cumulative infec-
tions, to which 180 hospitalizations were added. The average
age among all COVID-19 decedents was 76.9 years (SD, 13.1).
The overall noninstitutionalized IFR was 0.26%. In order of
magnitude, the demographic-stratified IFR varied most by
age, race, ethnicity, and sex (Table). Persons younger than 40
years had an IFR of 0.01%; those aged 60 or older had an IFR
of 1.71%. Whites had an IFR of 0.18%; non-Whites had an IFR
of 0.59%.
Discussion: By using SARS-CoV-2 population prevalence
data, we found that the risk for death among infected persons
increased with age. Indiana's IFR for noninstitutionalized per-
sons older than 60 years is just below 2% (1 in 50). In compar-
ison, the ratio is approximately 2.5 times greater than the es-
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Infections (95% CI), n
Noninstitutionalized
IFR (95% CI), %
Age, y
<40 14 32.8 13 108 339 (73 041–142 095) 0.01 (0.01–0.02)
40–59 81 52.4 63 52 917 (33 963–71 546) 0.12 (0.09–0.19)
≥60 1004 79.5 419 24 493 (16 691–33 232) 1.71 (1.28–2.58)
Race
White 715 78.9 250 141 026 (108 858–171 519) 0.18 (0.15–0.23)
Non-White 384 73.3 245 41 583 (17 630–71 822) 0.59 (0.34–1.41)
Ethnicity
Hispanic 17 72.9 15 39 783 (10 851–73 317) 0.04 (0.02–0.14)
Non-Hispanic 1082 77.0 480 142 844 (118 830–172 653) 0.34 (0.28–0.41)
Sex
Male 580 74.9 300 107 891 (64 803–169 979) 0.28 (0.18–0.47)
Female 493 79.5 169 0.21 (0.16–0.32)
Total 1099 76.9 495
82 096 (53 116–109 200) 
187 378 (143 881–232 883) 0.26 (0.21–0.35)
IFR = infection fatality ratio.
* Mean age in years at the time of death, among total deaths.
† Excludes deaths among nursing home residents.
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timated IFR for seasonal influenza, 0.8% (1 in 125), among
those aged 65 years and older (5). Of note, the IFR for non-
Whites is more than 3 times that for Whites, despite
COVID-19 decedents in that group being 5.6 years younger
on average.
We are unaware of any similar IFR estimates by demo-
graphic group but recognize several limitations of our analy-
sis. First, despite random selection and weighting for nonre-
sponse, the potential for response bias remains. Second,
imperfections in tests have the potential for false-positives,
which may bias estimated infections upward. Separately, use
of confirmed COVID-19 deaths may undercount the true num-
ber of deaths; both issues might result in lower IFRs. Third,
because children and non–state tax filers were excluded, our
estimates may lack generalizability to persons who were not
studied. Fourth, we could not account for disease severity
among random-sample participants with positive test results.
Although participants represented persons with less severe
illness, some with positive test results may have later died of
COVID-19, resulting in a potential underestimation of the IFR.
However, accounting for right-censoring bias also might over-
estimate the IFR, because we cannot distinguish deaths
among persons we randomly tested from those among pa-
tients who were hospitalized during the testing period. Race
and ethnicity data for confirmed COVID-19 deaths may have
been inaccurate, thus biasing these IFR estimates. Lastly, IFR is
a population-based measure and should be interpreted cau-
tiously as a measure of individual risk.
Justin Blackburn, PhD
Constantin T. Yiannoutsos, PhD
Indiana University Richard M. Fairbanks School of Public
Health, Indianapolis, Indiana
Aaron E. Carroll, MD, MS
Indiana University School of Medicine, Indianapolis, Indiana
Paul K. Halverson, DrPH
Nir Menachemi, PhD, MPH
Indiana University Richard M. Fairbanks School of Public
Health, Indianapolis, Indiana
Financial Support: This study was funded by the State of Indiana.
Disclosures: Disclosures can be viewed at www.acponline.org
/authors/icmje/ConflictOfInterestForms.do?msNum=M20-5352.
Reproducible Research Statement: Study protocol: Available from
Dr. Blackburn (e-mail, jblackb@iu.edu). Statistical code: Not available.
Data set: Available from the Indiana State Department of Health (www
.coronavirus.in.gov/2397.htm).
Corresponding Author: Justin Blackburn, PhD, 1050 Wishard Bou-
levard, Indianapolis, IN 46202; e-mail, jblackb@iu.edu.
doi:10.7326/M20-5352
References
1. Park M, Cook AR, Lim JT, et al. A systematic review of COVID-19 epidemi-
ology based on current evidence. J Clin Med. 2020;9. [PMID: 32244365] doi:
10.3390/jcm9040967
2. Russell TW, Hellewell J, Jarvis CI, et al. Estimating the infection and case
fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from
the outbreak on the Diamond Princess cruise ship, February 2020. Euro
Surveill. 2020;25. [PMID: 32234121] doi:10.2807/1560-7917.ES.2020.25.12
.2000256
3. Basu A. Estimating the infection fatality rate among symptomatic COVID-19
cases in the United States. Health Aff (Millwood). 2020;39:1229-1236. [PMID:
32379502] doi:10.1377/hlthaff.2020.00455
4. Menachemi N, Yiannoutsos CT, Dixon BE, et al. Population point prevalence
of SARS-CoV-2 infection based on a statewide random sample - Indiana, April
25-29, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:960-964. [PMID:
32701938] doi:10.15585/mmwr.mm6929e1
5. Centers for Disease Control and Prevention. Estimated influenza illnesses,
medical visits, hospitalizations, and deaths in the United States—2018–2019
influenza season. Accessed at www.cdc.gov/flu/about/burden/2018-2019
.html on 4 June 2020.
LETTERS
2 Annals of Internal Medicine Annals.org
Correction: This article was corrected on 3 September 2020 to fix  
inaccurate values within the male and female categories in the table.
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